Jasvinder Banga

Jasvinder Banga is currently serving as Associate Director of Oncology Forecasting and Analytics at Regeneron since February 2025. Prior experience includes a role as Senior Manager of Forecasting at Amgen, where responsibility encompassed US forecasting for GBU & NBURare Diseases and marketing analytics following the acquisition of Horizon Therapeutics in October 2023. Jasvinder's earlier positions include Staff Forecast Analyst at Dexcom, where duties involved sophisticated forecasting, demand planning, and market analytics, and a strategic consultant role at PharmaACE, focusing on long-term financial planning and forecasting models in various therapeutic areas. Additionally, a business analyst position at Novo Nordisk involved commercial effectiveness and marketing analytics. Educational credentials include an MBA in Pharmaceutical Marketing from the National Institute of Pharmaceutical Education and Research and a B.Pharma from Delhi University.